Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-020372
Filing Date
2025-07-21
Accepted
2025-07-21 12:03:58
Documents
1
Period of Report
2025-07-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7310
  Complete submission text file 0001641172-25-020372.txt   9020
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Reporting) CIK: 0001689739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 251136428